Memorial Sloan Kettering brings a vast body of knowledge and expertise to the care of patients with cancer of unknown primary origin. Many recent advances in diagnosing and treating cancer of unknown primary origin — and improvements in survival and quality of life — can be attributed to our multidisciplinary team of doctors.
Your patient care team typically consists of a medical oncologist who specializes in CUP tumors, as well as surgeons, radiation oncologists, and other doctors with the necessary expertise to treat the type of cancer you have. In some cases, for example, your team may also include gastroenterologists, endocrinologists, or pulmonologists. Nurses, social workers, and other healthcare professionals are also available to help you through your treatment.
The following is a list of our experts in cancer of unknown primary origin.
Eileen M. O'Reilly
Associate Director for Clinical Research, David M. Rubenstein Center for Pancreatic Cancer Research; Winthrop Rockefeller Chair of Medical Oncology
Jennifer R. Cracchiolo
Rodrigo Erlich
Jung Julie Kang
David Paul Kelsen
Edward S. Gordon Chair in Medical Oncology
David S. Klimstra
Chair, Department of Pathology; James Ewing Alumni Chair of Pathology
Leonard Saltz
Executive Director for Clinical Value & Sustainability; Head, Colorectal Oncology Section
Anna M. Varghese
Stephen R. Veach
Laura H. Tang
